@GeorgeDunham@dfwticket Not sure but I am interested in the discussion about the FCC threatening ABC - can you reply to me where the FCC said that? Also I was looking back thru your tweets, I could not find where you discussed the Biden administration stifling free speech on X during the COVID pandemic
@LauraKruperMD@ASBrS@DrNimmiKapoor Should we be looking at the treatment data for GM? Are there studies showing steroids work better than watchful waiting?
@doctorkarpoff If only there was a test that could determine benefit of radiation therapy in patients with DCIS….oh wait, there is DCISionRT by Prelude!
NEWS ALERT: Aptitude Health Acquires TME BCN. The company will expand into the oncology breast surgery space and accelerate the growth of its physician network:
https://t.co/ZoJ5A0NNWk
@ness_atn great article
I’ve had similar condition since birth like Cam. Let’s get better treatment🦋@LymphedemaAct @MsKathyBates
https://t.co/0W84VOKWxw
What happens in Vegas…..@ASBrS22 @IronwoodCancer. I love my partners and am excited for these future breast surgeons at the American Society of Breast Surgeons meeting. So good to be together!
New portable scalp cooling system to mitigate chemotherapy related hair loss!
Cooler Heads - One Minute Video Competition https://t.co/O3iQVZ7QfG via @YouTube
‘Aggressive prostate cancer’ is a subjective term, Gleason score is judged by humans - 6 not aggressive and 7 is aggressive.... Isn’t it time to germline test all prostate cancer patients? All cancer patients? #freeTheDNA@DrRakeshPatel@md_rosen@WhitworthMD@NoelPugh
It’s estimated that 13% of men in the U.S. will develop prostate #cancer within their lifetime.
Recently updated #NCCN guidelines recommend that all men with aggressive #prostatecancer consider #genetictesting, regardless of family history. Learn more: https://t.co/ZI3KG4WfcU
@Med_neon ‘Aggressive prostate cancer’ is a subjective term, Gleason score is judged by humans - 6 not aggressive and 7 is aggressive.... Isn’t it time to germline test all prostate cancer patients? All cancer patients? #FreeTheDNA@DrRakeshPatel@WhitworthMD
The emperor (NCCN) is still naked - guidelines to decide which cancer patients need germline genetic testing DO NOT WORK & harm patients AND THEIR FAMILIES! It is time to pressure the @NCCN to change their antiquated economic road blocks (guidelines). #FreetheDNA@DrRakeshPatel
New @MayoClinic study finds that 1 in 6 patients with #colorectalcancer had an inherited cancer-related gene mutation, which likely predisposed them to the disease. Researchers also discovered that 60% of cases would not have been detected with a standard guideline-based approach
@Med_neon@MayoClinic The emperor (NCCN) is still naked - guidelines to decide which cancer patients need germline genetic testing DO NOT WORK & harm patients AND THEIR FAMILIES! It is time to pressure the @NCCN to change their antiquated economic road blocks (guidelines). #FreetheDNA@DrRakeshPatel
Genomicists & clinicians are beginning to offer patients #genomictesting for a list of treatable diseases apart from the one that brought them into the clinic. Learn about the role secondary findings play in diagnosing #diseases & saving lives:
https://t.co/zxqWMbzgsZ